1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream
Generic Name: 1.85% hydrocortisone acetate - 1.15% pramoxine hci cream
Brand Names:
Procort
DESCRIPTION: ProCort® is a topical preparation containing hydrocortisone acetate 1.85% and pramoxine hydrochloride 1.15% in a hydrophilic and hydrophobic cream base which contains patented *Invisicare M1 polymer technology.
Overview
DESCRIPTION: ProCort® is a topical preparation containing hydrocortisone acetate 1.85% and pramoxine hydrochloride 1.15% in a hydrophilic and hydrophobic cream base which contains patented *Invisicare M1 polymer technology.
Uses
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage
topical corticosteroids are generally applied to the affected area as a thin film 3 to 4 times daily, depending on the severity of the condition. Occlusive dressing may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted. Directions for rectal administration: 1. To open, remove foil, tab or puncture foil seal with cap. 2. Remove the applicator’s wrapping and attach the applicator to the tube. 3. Squeeze the tube to fill the applicator and lubricate the tip with cream. 4. Gently insert the applicator into rectum and squeeze tube begin to force the required amount of cream into rectum. 5. Wipe applicator tip clean remove and discard. 6.
Side Effects
The following local adverse reactions are reported in frequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence; itching, burning, skin irritation.
Warnings
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Storage
ProCort® insert registered symbol,storage condition: store at 25°C (77°F); excursions permitted to 15–30°C (59 to 86°F.)[see USP controlled room temperature]. Rx only. Distributed by: Women’s Choice, Pharmaceuticals, Berwyn, PA 19312 Www.wcpharma.com
Frequently Asked Questions
What is 1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream used for?▼
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
What are the side effects of 1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream?▼
The following local adverse reactions are reported in frequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence; itching, burning, skin irritation.
What are the important warnings for 1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream?▼
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Related Medications
Diethylstilbestrol Diphosphate
diethylstilbestrol diphosphate
Manufactured by BAYER PHARMS. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: DIETHYLSTILBESTROL DIPHOSPHATE (250MG/5ML). Application: NDA010010.
Apomorphine Hydrochloride
apomorphine hydrochloride
11 DESCRIPTION ONAPGO (apomorphine hydrochloride) contains apomorphine hydrochloride hemihydrate, a non-ergoline dopamine agonist. It is chemically designated as 6aβ-aporphine-10,11-diol hydrochloride hemihydrate with a molecular formula of C 17 H 17 NO 2 ∙HCl∙½H 2 O. Its structural formula and molecular weight are: Apomorphine hydrochloride hemihydrate appears as minute, white or grayish-white glistening crystals or as white powder that is soluble in water at 80°C.
Retifanlimab
retifanlimab
Dosage form: SOLUTION. Active ingredients: RETIFANLIMAB (25 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.